Stocks and Investing
Stocks and Investing
Tue, July 17, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, July 16, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Louise Chen Maintained (TEVA) at Hold with Increased Target to $25 on, Jul 16th, 2018
Louise Chen of Cantor Fitzgerald, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $18 to $25 on, Jul 16th, 2018.
Louise has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Louise's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Upgraded from Sell to Hold on, Monday, June 18th, 2018
- Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $20 on, Thursday, May 24th, 2018
- David Risinger of "Morgan Stanley" Maintained at Hold on, Monday, May 7th, 2018
This is the rating of the analyst that currently disagrees with Louise
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $25 on, Thursday, May 31st, 2018